A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies

Journal of Neuroscience Methods

Volumn 155, Issue 2, 2006, Pages 224-230

  Bridi, Raquel ^a   Fontella, Fernanda U ^a   Pulrolnik, Vânia ^a   Braun, César A ^a   Zorzi, Giovanni K ^a   Coelho, Daniella ^b   Wajner, Moacir ^a,b   Vargas, Carmen Regla ^a,b   Dutra Filho, Carlos Severo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Acute animal model; Branched chain amino acids; Maple syrup urine disease; Rats

Indexed keywords

ALANINE; BRANCHED CHAIN AMINO ACID; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; ORNITHINE; PHENYLALANINE; TYROSINE; VALINE;

AMINO ACID BLOOD LEVEL; AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAPLE SYRUP URINE DISEASE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

AMINO ACIDS; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; ANIMALS, NEWBORN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ELECTROCHEMISTRY; MALE; MAPLE SYRUP URINE DISEASE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33747204835     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.01.005     Document Type: Article

References (26)

1. Araújo P., Wassermann G.F., Tallini K., Furlanetto V., Vargas C.R., Wannmacher C.M.D., et al. Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38 (2001) 529-533
2. Bridi R., Araldi J., Sgarbi M.B., Testa C.G., Durigon K., Wajner M., et al. Induction of oxidative stress in rat brain by the metabolite accumulating in maple syrup urine disease. Int J Dev Neurosci 21 (2003) 327-332
3. Bridi R., Latini A., Braum C.A., Zorzi G.K., Wajner M., Lissi E., et al. Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats. Free Radic Res 31 9 (2005) 71-79
4. Chuang D.T., and Shih V.E. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York 1971-2005
5. Danner D.J., and Elsas II L.J. Disorders of branched chain amino acid and keto acid metabolism. In: Scriver C.R., Beaudet A.L., Sly W.L., and Valle D. (Eds). The metabolic basis of inherited disease (1989), McGraw-Hill, New York 671-692
6. Dodd P.R., Wiliams A.L., Gundlach A.L., Harper P.A.W., Healy P.J., Dennis J.A., et al. Glutamate and γ-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem 59 (1992) 582-590
7. Fernstron J.D. Branched-chain amino acids and brain function. J Nutr 135 (2005) 1539S-1546S
8. Fontella F.U., Gassen E., Pulrolnik V., Wannmacher C.M.D., Klein A.B., Wajner M., et al. Stimulation of lipid peroxidation in vitro in rat brain by metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17 (2002) 47-54
9. Halestrap A.P., Brand M.D., and Denton R.M. Inhibition of mitochondrial pyruvate transport by phenylpyruvate and α-ketoisocaproate. Biochem Biophys Acta 367 (1974) 102-108
10. Harper P.A., Healy P.J., and Dennis J.A. Maple syrup urine disease as a cause of spongiform encephalopathy in calves. Vet Rec 119 (1986) 62-65
11. Joseph M.H., and Marsden C.A. Amino acids and small peptides. In: Lim C.K. (Ed). HPLC of small peptides (1986), IRL Press, Oxford 13-27
12. Jouvet P., Rustin P., Taylor D.L., Pocock J.M., Felderhoff-Mueser U., Mazarakis N.D.C., et al. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane despolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11 (2000) 1919-1932
13. Land J.M., Mowbray J., and Clark J.B. Control of pyruvate and β-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J Neurochem 26 (1976) 823-830
14. Lowry O.H., Rosebrough N.J., Lewis-Farr A., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
15. Morton D.H., Strauss K.A., Robinson D.L., Puffenberger E.G., and Kelley R.I. Diagnosis and treatment of maple sryup disease: a study of 36 patients. Pediatrics 109 (2002) 909-1008
16. Nyhan W.L. Maple syrup urine disease: branched-chain ketoaciduria. In: Nyhan W.L. (Ed). Abnormalities in amino acid metabolism in clinical medicine (1984), Appleton-Century-Crofts, Norwalk 21-35
17. Pilla C., Cardozo R.F., Dornelles P.K., Dutra-Filho C.S., Wyse A.T., Wajner M., et al. Kinetic studies on the inhibition of creatine kinase activity by branched-chain alpha-amino acids in the brain cortex of rats. Int J Dev Neurosci 21 (2003) 145-151
18. Pilla C., Cardozo R.F., Dutra-Filho C.S., Wyse A.T., Wajner M., and Wannmacher C.M. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem Res 28 (2003) 675-679
19. Prensky A.L., and Moser H.W. Changes in the amino acid composition of proteolipids of white matter during maturation of the human nervous system. J Neurochem 14 (1967) 117-121
20. Snyderman S.E., Norton P.M., and Roitman E. Maple syrup urine disease with particular reference to diet therapy. Pediatrics 34 (1964) 454-472
21. Tavares R.G., Santos C.E.S., Tasca C., Wajner M., Souza D.O., and Dutra-Filho C.S. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 181 (2000) 44-49
22. Wajner M., Coelho D.M., Barschak A.G., Araujo P.R., Pires R.F., Lulhier F.L., et al. Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises. J Inherit Metab Dis 23 (2000) 505-512
23. Wajner M., and Vargas C.R. Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises. Arch Dis Child 80 (1999) 579
24. Wu J.Y., Kao H.J., Li S.C., Stevens R., Hillman S., Millington D., et al. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J Clin Invest 113 (2004) 434-440
25. Yudkoff M., Daikhin Y., Lin Z.P., Nissim I., Stern J., Pleasure D., et al. Interrelationships of leucine and glutamate metabolism in cultured astrocyts. J Neurochem 62 (1994) 1192-1202
26. Zielke H.R., Zielke C.L., Baab P.J., and Collins R.M. Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implications for maple syrup urine disease and phenylketonuria. Neurochem Int 40 (2002) 347-354